<div id="readability-page-1">03:41 PM EST, 12/23/2025 (MT Newswires) -- Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, Pfizer ( PFE ) shares were down 1.4% after it said Tuesday that a participant in its long-term extension trial evaluating Hympavzi in hemophilia died after serious adverse events of cerebellar infarction and cerebral hemorrhage.Novo Nordisk ( NVO ) shares jumped past 7% after it said late Monday the US Food and Drug Administration approved its Wegovy pill for weight management and to reduce the risk of major adverse cardiovascular events.Johnson &amp; Johnson ( JNJ ) has been ordered by a Baltimore jury to pay more than $1.5 billion to a single plaintiff, who claimed that the use of the pharmaceutical giant's talc-based baby powder products caused her cancer. Johnson &amp; Johnson ( JNJ ) shares were shedding 1%.RxSight ( RXST ) shares fell past 10% after the company said late Monday that chief financial officer Shelley Thunen will transition from her role. Thunen will remain with the company until the sooner of the appointment of a new CFO or Jan. 31, 2026. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

諾和諾德公司

輝瑞

強生

醫療保健股票表現參差不齊，紐約證券交易所醫療保健指數小幅上漲，而 XLV 下跌 0.3%。由於一名試驗參與者的死亡，輝瑞的股價下跌了 1.4%。諾和諾德的股價在 FDA 批准其 Wegovy 藥丸後上漲超過 7%。強生因一宗與滑石粉相關的訴訟被判支付 15 億美元，導致股價下跌 1%。RxSight 在宣佈首席財務官更換後股價下跌超過 10%

Sector Update: Health Care Stocks Mixed Late Afternoon

- 健康護理股走勢不一，NYSE 健康護理指數小幅上漲，XLV 下跌 0.3%。  
- 輝瑞（Pfizer）股價下跌 1.4%，因一名試驗參與者因嚴重不良事件去世。  
- 諾和諾德（Novo Nordisk）股價上漲超過 7%，因 FDA 批准其 Wegovy 藥片用於體重管理。

板塊更新：醫療保健類股在午後交易中表現不一